FDA and RU-486 : Lowering the Standard for Women's Health.

Food and Drug Administration : approval and oversight of the drug Mifeprex : report to congressional requesters.
Published: (2008)

Clinical applications of mifepristone (RU 486) and other antiprogestins : assessing the science and recommending a research agenda /
Published: (1993)

RU-486, status report on the U.S. commercialization project, transfer of antiprogestin technology to the United States : hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, second session, Washington, DC, May 16, 1994.
Published: (1994)

The effect of federal ban of RU 486 on medical research, new drug development, and pharmaceutical manufacturers : hearing before the Subcommittee on Regulation, Business Opportunities, and Energy of the Committee on Small Business, House of Representatives, One Hundred Second Congress, second session, Washington, DC, July 28, 1992.
Published: (1992)

Food and Drug Administration: information on Mifeprex labeling changes and ongoing monitoring efforts : report to congressional requesters.
Published: (2018)

FDA Food Additive Review Process : Backlog and Failure To Observe Statutory Deadline.
Published: (1995)

Decline in FDA Enforcement Efforts.
Published: (2005)

Medication abortion access remains unchanged as supreme court rejects legal challenge on standing grounds /
by: Staman, Jennifer A.
Published: (2024)

S. 1082 -- The FDA Revitalization Act.
Published: (2007)

The need for FDA reform : hearing before the Subcommittee on Health and Environment of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, second session, February 27, 1996.
Published: (1996)

Challenges for the FDA : the future of drug safety : workshop summary /
Published: (2007)

FDA laboratories : magnitude of benefits associated with consolidation is questionable : report to congressional requesters /
Published: (1996)

FDA : safeguarding America's health.
Published: (1990)

Medication abortion: a changing legal landscape /
by: Staman, Jennifer A., et al.
Published: (2022)

Weaknesses in FDA's Food Safety System : Fact Sheet.
Published: (2006)

FDA oversight : medical devices : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, Ninety-seventh Congress, second session, July 16, 1982.
Published: (1982)

RU 486 : the import ban and its effect on medical research : hearing before the Subcommittee on Regulation, Business Opportunities, and Energy of the Committee on Small Business, House of Representatives, One Hundred First Congress, second session, Washington, DC, November 19, 1990.
Published: (1991)

RU 486 (MifePristone) : Conditional Approval by the Food and Drug Administration.
Published: (1997)

The FDA /
by: Lucas, Scott, 1937-
Published: (1978)

Building a 21st century FDA : proposals to improve drug safety and innovation : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, second session, on examining proposals to improve drug safety and innovation, and S. 3807, to amend the Public Health Service Act and the Federal Food, Drug, and Cosmetic Act to improve drug safety and oversight, November 16, 2006.
Published: (2007)

Building a 21st century FDA : proposals to improve drug safety and innovation : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, second session, on examining proposals to improve drug safety and innovation, and S. 3807, to amend the Public Health Service Act and the Federal Food, Drug, and Cosmetic Act to improve drug safety and oversight, November 16, 2006.
Published: (2007)

FDA regulation of blood safety : notification, recall, and enforcement practices : hearing before the Subcommittee on Human Resources of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, first session, June 5, 1997.
Published: (1998)

Science at the FDA : the mainstay of public health protection, new technology is FDA's greatest challenge.
Published: (2002)

Restoring FDA's ability to keep America's families safe : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Tenth Congress, second session, on examining the U.S. Food and Drug Administration, focusing on its ability to ensure the safety of food and the drug supply in the United States, April 24, 2008.
Published: (2009)

Restoring FDA's ability to keep America's families safe : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Tenth Congress, second session, on examining the U.S. Food and Drug Administration, focusing on its ability to ensure the safety of food and the drug supply in the United States, April 24, 2008.
Published: (2009)

The FDA follies /
by: Burkholz, Herbert, 1932-2006
Published: (1994)

FDA medical bulletin.
Published: (1991)

Drug Safety : Better Data Management and More Inspections Are Needed To Strengthen FDA's Foreign Drug Inspection Program.
Published: (2008)

FDA consumer protection activities--FDA reorganization : hearings, Ninety-first Congress, first and second session ...
Published: (1970)

FDA administrative enforcement manual /
by: Parker, Florence R.
Published: (2005)

FDA warning letters about food products : how to avoid or respond to citations /
by: Frestedt, Joy L.
Published: (2017)

FDA's independent evaluation of its food safety programs /
by: Nair, Amber D.
Published: (2023)

Modernizing FDA's regulation of over-the-counter drugs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session. September 13, 2017.
Published: (2018)

FDA protetects the public health : ranks high in public trust.
Published: (2002)

FDA almanac.

FDA inspections of domestic food facilities.
Published: (2010)